Firebrick Pharma Limited (FRE.AX)
AUD 0.05
(1.89%)
AUD 0.05
(1.89%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -824.77 Thousand AUD | 64.97% |
| 2023 | -2.35 Million AUD | 67.04% |
| 2022 | -7.14 Million AUD | 34.32% |
| 2021 | -10.87 Million AUD | -28302.47% |
| 2020 | -38.29 Thousand AUD | 93.37% |
| 2019 | -577.46 Thousand AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 FY | -824.77 Thousand AUD | 64.97% |
| 2024 Q2 | -1.3 Million AUD | 0.0% |
| 2024 Q4 | -824.77 Thousand AUD | 0.0% |
| 2024 Q3 | -824.77 Thousand AUD | 36.8% |
| 2024 Q1 | -1.3 Million AUD | 44.58% |
| 2023 FY | -2.35 Million AUD | 67.04% |
| 2023 Q4 | -2.35 Million AUD | 0.0% |
| 2023 Q3 | -2.35 Million AUD | 52.04% |
| 2023 Q2 | -4.9 Million AUD | 0.0% |
| 2023 Q1 | -4.9 Million AUD | 31.27% |
| 2022 Q2 | -4.22 Million AUD | 0.0% |
| 2022 FY | -7.14 Million AUD | 34.32% |
| 2022 Q4 | -7.14 Million AUD | 0.0% |
| 2022 Q3 | -7.14 Million AUD | -69.18% |
| 2022 Q1 | -4.22 Million AUD | -266.58% |
| 2021 Q4 | -1.15 Million AUD | 0.0% |
| 2021 Q3 | -1.15 Million AUD | 0.0% |
| 2021 Q1 | 92.7 Thousand AUD | 0.0% |
| 2021 FY | -10.87 Million AUD | -28302.47% |
| 2020 FY | -38.29 Thousand AUD | 93.37% |
| 2019 FY | -577.46 Thousand AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Mayne Pharma Group Limited | -78.42 Million AUD | 98.948% |